Susceptibility of deer mice and California mice to COVID-19

NewsGuard 100/100 Score

In a recent study posted to the bioRxiv* preprint server, researchers assessed the susceptibility of deer mice and California mice to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

Study: SARS-CoV-2 infects multiple species of North American deer mice and causes clinical disease in the California mouse. Image Credit: jitkagold/Shutterstock
Study: SARS-CoV-2 infects multiple species of North American deer mice and causes clinical disease in the California mouse. Image Credit: jitkagold/Shutterstock

This news article was a review of a preliminary scientific report that had not undergone peer-review at the time of publication. Since its initial publication, the scientific report has now been peer reviewed and accepted for publication in a Scientific Journal. Links to the preliminary and peer-reviewed reports are available in the Sources section at the bottom of this article. View Sources

The causative agent of coronavirus disease 2019 (COVID-19), SARS-CoV-2, emerged at the end of 2019 in Wuhan, China and has spread globally resulting in widespread morbidity and mortality. There have been rising concerns regarding the potential of SARS-CoV-2 in establishing endemicity within a secondary animal reservoir or acquire adaptations that could lead to the emergence of novel variants with the ability to reinfect humans.Previosu research has highlighted that North American deer mice are susceptible to COVID-19 and can serve as a transmission route for the virus, suggesting its potential as a wildlife reservoir for SARS-CoV-2.

About the study

In the present study, researchers reported the susceptibility of two subspecies of the North American deer mouse and California mice to SARS-CoV-2.

Nine young, adult deer mice of both sexes from each species or subspecies were intranasally exposed to SARS-CoV-2 to examine the vulnerability of the various deer mouse species and subspecies. On the first day of the experiment, three unchallenged controls belonging to each species group were necropsied after euthanization. On days six and 15, three SARS-CoV-2-exposed mice from each species were euthanized and their bodies were examined. The team collected an additional oral swab on day 10.

The team continued to develop California mice to be employed as an animal model of COVID-19. Daily oral swabs collected after the challenge were examined for viral ribonucleic acid (RNA) and infectious viruses. Testing for viral RNA and infectious viruses was also performed on lung homogenate obtained from mice euthanized on the third, sixth, and tenth days after SARS-CoV-2 exposure. Indirect enzyme-linked immunosorbent assay (ELISA) was employed to measure the amount of serum immunoglobulin G (IgG) and the serum neutralizing antibody titer in mice's serum collected on the third, sixth, and tenth days after the challenge.

Results

The study results showed that on day three post-challenge, one of the nine oral swabs obtained from each species cohort contained infectious virus, and a majority of lung samples derived from mice put to death on the third and sixth day post-challenge included viral RNA. On day 3 after the challenge, infectious virus was found in mouth swabs from three out of four species and viral RNA was found in oral swabs from all challenged mice, including Oldfield mouse, prairie deer mouse, and California mouse. On day 15 after the challenge, the Oldfield mouse, Sonora white-footed mouse, and prairie deer mouse all had detectable neutralizing antibodies, with a mean geometric mean titer of 87.

At any point during the investigation, neither the Oldfield mouse nor the prairie deer mouse displayed any clinical symptoms. Even though there were no additional clinical symptoms during the 15-day exposure testing, the Sonora white-footed mice exhibited a reduction in body weight. Two California mice (one male and one female) were seen to exhibit ruffled fur, a stooped posture, and a lethargic attitude on day three following the challenge.

The male California mice showed signs of improvement when assessed on day 4, but the female subjects were moribund and had to be humanely put to sleep for necropsy. Hepatomegaly and a distinct hepatic reticular pattern were present in this mouse. The mouse was suspected to be experiencing hepatic lipidosis.

Research also revealed that the mice contracted the virus because viral RNA was found in their lungs and oral swabs as early as day ten after the challenge. On the first, second, and third day following the challenge, mouth swabs and all of the lungs were found to contain an infectious virus. Ten days after the challenge, serum IgG to viral nucleocapsid was found in all animals, and five of the six mice had neutralizing antibodies. On days 1 and 3 after the challenge, the SARS-CoV-2-exposed group lost significantly more weight than the unchallenged controls. As opposed to the infected controls, the control mice's weight had significantly decreased by day ten.

Comparing the SARS-CoV-2-challenged California mice to the uninfected controls, the weight loss on days 1 and 3 after the challenge was significantly higher in the former group. On day ten following the challenge, the uninfected control group had lost noticeably more weight than the challenged group.

The most severe inflammation was detected in the lungs and nasal passages in all animals. Heart, liver, nasal skin, and mucosa did not exhibit significant histologic variations across groups. The most severely affected organ was the lung. Infected mice exhibited varying degrees of interstitial lymphohistiocytic and fibrinous pneumonia with edema, reactive vascular endothelium characterized by neutrophil margination and perivasculitis, and minimal to mild bronchial epithelial hyperplasia.

Overall, the study findings showed that two subspecies of the North American deer mouse and three species of deer mice, including the California mouse, the North American deer mouse, and the Oldfield mouse, are susceptible to SARS-CoV-2 infection.

This news article was a review of a preliminary scientific report that had not undergone peer-review at the time of publication. Since its initial publication, the scientific report has now been peer reviewed and accepted for publication in a Scientific Journal. Links to the preliminary and peer-reviewed reports are available in the Sources section at the bottom of this article. View Sources

Journal references:

Article Revisions

  • May 15 2023 - The preprint preliminary research paper that this article was based upon was accepted for publication in a peer-reviewed Scientific Journal. This article was edited accordingly to include a link to the final peer-reviewed paper, now shown in the sources section.
Bhavana Kunkalikar

Written by

Bhavana Kunkalikar

Bhavana Kunkalikar is a medical writer based in Goa, India. Her academic background is in Pharmaceutical sciences and she holds a Bachelor's degree in Pharmacy. Her educational background allowed her to foster an interest in anatomical and physiological sciences. Her college project work based on ‘The manifestations and causes of sickle cell anemia’ formed the stepping stone to a life-long fascination with human pathophysiology.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Kunkalikar, Bhavana. (2023, May 15). Susceptibility of deer mice and California mice to COVID-19. News-Medical. Retrieved on April 25, 2024 from https://www.news-medical.net/news/20220825/Susceptibility-of-deer-mice-and-California-mice-to-COVID-19.aspx.

  • MLA

    Kunkalikar, Bhavana. "Susceptibility of deer mice and California mice to COVID-19". News-Medical. 25 April 2024. <https://www.news-medical.net/news/20220825/Susceptibility-of-deer-mice-and-California-mice-to-COVID-19.aspx>.

  • Chicago

    Kunkalikar, Bhavana. "Susceptibility of deer mice and California mice to COVID-19". News-Medical. https://www.news-medical.net/news/20220825/Susceptibility-of-deer-mice-and-California-mice-to-COVID-19.aspx. (accessed April 25, 2024).

  • Harvard

    Kunkalikar, Bhavana. 2023. Susceptibility of deer mice and California mice to COVID-19. News-Medical, viewed 25 April 2024, https://www.news-medical.net/news/20220825/Susceptibility-of-deer-mice-and-California-mice-to-COVID-19.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Global study reveals mismatch in COVID-19 treatment guidelines with WHO standards